| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,995 |
6,231 |
$611K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,579 |
5,170 |
$327K |
| 80305 |
|
3,067 |
1,952 |
$21K |
| 99215 |
Prolong outpt/office vis |
232 |
154 |
$18K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
419 |
168 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
144 |
94 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
169 |
123 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
585 |
388 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
292 |
156 |
$2K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
98 |
49 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
21 |
12 |
$1K |
| 99406 |
|
505 |
272 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
34 |
18 |
$784.75 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
24 |
16 |
$622.35 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
13 |
$365.03 |
| 96127 |
|
43 |
16 |
$20.42 |
| 99490 |
Ccm add 20min |
136 |
115 |
$0.00 |